vilanterol in patients with COPD: results on cardiovascular safety…

Overview of attention for article published in Respiratory Research, June 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 8 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 51 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 14,941 followers.

RT @ATS_BSHSR: #Single- #inhaler #Triple #Therapy #Fluticasone #Furoate/ #Umeclidinium/ #Vilanterol Versus #Fluticasone #Furoate/ #Vilanter…

24 Jun 2020

Reply Repost Favourite

RT @ATS_BSHSR: #Single- #inhaler #Triple #Therapy #Fluticasone #Furoate/ #Umeclidinium/ #Vilanterol Versus #Fluticasone #Furoate/ #Vilanter…

17 Jun 2020

Reply Repost Favourite

Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Results on Cardiovascular Safety From the IMPACT Trial - PubMed https://t.co/3jaieb2Vij

14 Jun 2020

Reply Repost Favourite

RT @ATS_BSHSR: #Single- #inhaler #Triple #Therapy #Fluticasone #Furoate/ #Umeclidinium/ #Vilanterol Versus #Fluticasone #Furoate/ #Vilanter…

13 Jun 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.